BERKELEY, Calif.--(BUSINESS WIRE)--July 17, 2006--Bayer HealthCare today announced the launch of the Kogenate® FS with BIO-SET® Free Trial Program. The Program gives individuals with hemophilia A in the United States a one-time opportunity to experience treatment with Kogenate FS (Antihemophilic Factor (Recombinant), Formulated with Sucrose) with BIO-SET, a needleless reconstitution system, as well as the accompanying support programs and services available through Bayer. Kogenate FS with BIO-SET is the first integrated reconstitution system for recombinant factor VIII that avoids the risk of accidental needle-stick injuries during reconstitution.
